Where I see patients (2)
Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant.
Journal of the American Society of Nephrology : JASN
State of the art in childhood nephrotic syndrome: concrete discoveries and unmet needs.
Frontiers in immunology
Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial.
Daratumumab and Belatacept for Desensitization
Proportion of subjects who have not met a subject stopping rule, and remain free of all of the following through 26 weeks after starting treatment or until receiving a transplant, whichever occurs earlier: Grade 3 or higher infusi...